
- /
- Supported exchanges
- / US
- / MDXG.NASDAQ
MiMedx Group Inc (MDXG NASDAQ) stock market data APIs
MiMedx Group Inc Financial Data Overview
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get MiMedx Group Inc data using free add-ons & libraries
Get MiMedx Group Inc Fundamental Data
MiMedx Group Inc Fundamental data includes:
- Net Revenue: 352 M
- EBITDA: 62 809 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-28
- EPS/Forecast: 0.055
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MiMedx Group Inc News

Northland sees ‘key positive’ for MiMedx in CMS rule proposal
Northland analyst Carl Byrnes says the CMS is taking action to curb skin substitute spending with its 2026 physician fee schedule proposed rule released last night. The rule would eliminate separate s...


MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026
MARIETTA, Ga., July 15, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today commented on the Centers for Medicare and Medicaid Services (“CMS”) r...

Biggest stock movers Tuesday: NVDA, TTD, and more
[Man looking at currency trading app on his smart phone from his home office] Alistair Berg Stock futures edged higher early Tuesday as investors awaited the kickoff of earnings season, with major ba...

CMS proposed payment rule aims to cut waste, boost chronic disease management
[Centers For Medicare And Medicaid Services Headquarters] A proposed payment rule unveiled Monday by CMS aims to reduce unnecessary spending and boost quality measures, as well as launch a new paymen...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.